ROCO
4431
Market cap25mUSD
Oct 08, Last price
22.35TWD
1D
9.29%
1Q
29.94%
Jan 2017
19.45%
IPO
78.51%
Name
Mytrex Health Technologies Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1990 and headquartered in Taoyuan, Taiwan, Mytrex Health Technologies, Inc. operates globally across Taiwan, Asia, Europe, and other international markets, specializing in the production and distribution of diverse non-woven fabrics. The company's offerings include advanced electrostatic filtration materials utilized in medical and industrial masks, as well as for various other filtration purposes. Additionally, Mytrex provides composite nonwoven products suitable for coolant and air filters, vacuum filter bags, HEPA and cabin filters, and water filtration compounds. Its portfolio also features thermal insulation materials for applications such as gloves, socks, shoes, hats, clothing, and mask insulation. Beyond manufacturing, Mytrex offers comprehensive services to hospitals, encompassing linen laundry and leasing, logistics support, and medical supply provisions. The company further extends its business to the sale of pharmaceuticals and medical hygiene items, alongside managing medical clothing products.
Key people
Xingyan Li
Deputy General Manager, Head of Finance & Accounting · since 2025
Yicheng Wu
Deputy General Manager · since 2020
Zhaoyuan Zeng
Deputy General Manager · since 1994
Director · since 2020
Chairman of the Board · since 2024
Wenren Yang
Director · since 2024
Changrong Zhang
Director · since 2017
Independent Director · since 2018
Hengyu Zhang
Independent Director · since 2019
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||